Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Anne Pariser"'
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 17, Iss 1, Pp 1-11 (2022)
Abstract Background To provide a comprehensive assessment of the total economic burden of rare diseases (RD) in the United States (U.S.) in 2019. We followed a prevalence-based approach that combined the prevalence of 379 RDs with the per-person dire
Externí odkaz:
https://doaj.org/article/7d37256498924e1590772938f3169704
Autor:
Qian Zhu, Ðắc-Trung Nguyễn, Timothy Sheils, Gioconda Alyea, Eric Sid, Yanji Xu, James Dickens, Ewy A. Mathé, Anne Pariser
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-12 (2021)
Abstract Background Limited knowledge and unclear underlying biology of many rare diseases pose significant challenges to patients, clinicians, and scientists. To address these challenges, there is an urgent need to inspire and encourage scientists t
Externí odkaz:
https://doaj.org/article/6436e90bae0b4f9dbe8bc63d5bd9cd97
Publikováno v:
Journal of Biomedical Semantics, Vol 11, Iss 1, Pp 1-13 (2020)
Abstract Background The Genetic and Rare Diseases (GARD) Information Center was established by the National Institutes of Health (NIH) to provide freely accessible consumer health information on over 6500 genetic and rare diseases. As the cumulative
Externí odkaz:
https://doaj.org/article/3fabd8e51dab44b9bcfa99e39bed536a
PDF file, 129KB, Definitions of Selected Regulatory Terms.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e8299d541db216b20ed026750aea80b
https://doi.org/10.1158/1078-0432.22455144.v1
https://doi.org/10.1158/1078-0432.22455144.v1
A systematic analysis of clinical trials supporting rare cancer drug approvals may identify concepts and terms that can inform the effective design of prospective clinical trials for rare cancers. In this article, using annual incidence ≤6 of 100,0
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cbd3cd2befd63131a6b1b28667a011e
https://doi.org/10.1158/1078-0432.c.6522939
https://doi.org/10.1158/1078-0432.c.6522939
PDF file, 201KB, Summary of FDA approval data for rare cancer indications from December 1987 to May 2011.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6061d96a42190d981de59da3323a9f03
https://doi.org/10.1158/1078-0432.22455150.v1
https://doi.org/10.1158/1078-0432.22455150.v1
Autor:
Carla, Epps, Ralph, Bax, Alysha, Croker, Dionna, Green, Andrea, Gropman, Agnes V, Klein, Hannah, Landry, Anne, Pariser, Marc, Rosenman, Michiyo, Sakiyama, Junko, Sato, Kuntal, Sen, Monique, Stone, Fumi, Takeuchi, Jonathan M, Davis
Publikováno v:
Therapeutic Innovation & Regulatory Science. 56:964-975
The literature thoroughly describes the challenges of pediatric drug development for rare diseases. This includes (1) generating interest from sponsors, (2) small numbers of children affected by a particular disease, (3) difficulties with study desig
Autor:
Ronald M. Summers, Eliot L. Siegel, Faraz Farhadi, Anne Pariser, Navid Hasani, Arman Rhamim, Babak Saboury, Moozhan Nikpanah, Yanji Xu, Michael A. Morris, Elizabeth C. Jones, Michael T. Collins
Publikováno v:
PET Clin
Almost 1 in 10 individuals can suffer from one of many rare diseases (RDs). The average time to diagnosis for an RD patient is as high as 7 years. Artificial intelligence (AI)-based positron emission tomography (PET), if implemented appropriately, ha
Autor:
Christine M. Cutillo, Hugh Dawkins, Oodaye Shukla, David A. Pearce, Pierantonio Russo, Cindy Hasche, Douglas Nowak, Ramaa Nathan, Ainslie Tisdale, Bryan Laraway, Melissa Haendel, Joni L. Rutter, Emily R. Griese, Chun-Hung Chan, Anne Pariser
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 16, Iss 1, Pp 1-18 (2021)
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases
Background Rare diseases (RD) are a diverse collection of more than 7–10,000 different disorders, most of which affect a small number of people per disease. Because of their rarity and fragmentation of patients across thousands of different disorde
Publikováno v:
Journal of Biomedical Semantics, Vol 11, Iss 1, Pp 1-13 (2020)
Journal of Biomedical Semantics
Journal of Biomedical Semantics
Background The Genetic and Rare Diseases (GARD) Information Center was established by the National Institutes of Health (NIH) to provide freely accessible consumer health information on over 6500 genetic and rare diseases. As the cumulative scientifi